MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
Harvard Bioscience Interest Expense 2011-2026 | HBIO
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Harvard Bioscience
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -227 K | 302 K | -666 K | -806 K | -469 K | 5.37 M | 713 K | 642 K | 854 K | 990 K | 955 K | 584 K | 752 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.37 M | -806 K | 692 K |
Quarterly Interest Expense Harvard Bioscience
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -365 K | -644 K | -324 K | - | -518 K | -181 K | -142 K | - | 45 K | -372 K | 432 K | - | -179 K | -62 K | 78 K | - | -130 K | -313 K | -34 K | - | -392 K | -191 K | 111 K | - | 1.35 M | 1.38 M | 1.4 M | - | 1.46 M | 1.48 M | 894 K | - | 189 K | 180 K | 163 K | - | 141 K | 180 K | 164 K | - | 204 K | 215 K | 222 K | - | 239 K | 248 K | 248 K | - | 276 K | 245 K | 130 K | - | 147 K | 152 K | 147 K | - | 216 K | 192 K | 195 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.48 M | -644 K | 197 K |
Interest Expense of other stocks in the Medical instruments industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
149 | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
408 M | $ 19.93 | 0.99 % | $ 10.2 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
-1 K | $ 8.71 | 3.75 % | $ 176 M | USA |
 |
Alcon
ALC
|
192 M | $ 81.19 | 0.07 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
-326 K | $ 36.37 | -1.57 % | $ 1.71 B | USA |
 |
Repro Med Systems
KRMD
|
561 K | $ 5.37 | -1.56 % | $ 245 M | USA |
 |
Haemonetics Corporation
HAE
|
-9.75 M | $ 65.87 | -0.15 % | $ 3.32 B | USA |
 |
electroCore
ECOR
|
6.3 M | $ 6.83 | -3.73 % | $ 37.7 K | USA |
 |
AngioDynamics
ANGO
|
4.94 M | $ 10.2 | 2.2 % | $ 417 M | USA |
 |
ICU Medical
ICUI
|
107 M | $ 149.04 | -0.66 % | $ 3.63 B | USA |
 |
InfuSystem Holdings
INFU
|
1.4 M | $ 8.14 | 1.12 % | $ 168 M | USA |
 |
The Cooper Companies
COO
|
-16.4 M | $ 80.95 | 0.72 % | $ 16.1 B | USA |
 |
Masimo Corporation
MASI
|
300 K | $ 134.5 | -1.29 % | $ 7.17 B | USA |
 |
Glaukos Corporation
GKOS
|
13.6 M | $ 117.26 | -1.43 % | $ 5.68 B | USA |
 |
Merit Medical Systems
MMSI
|
-711 K | $ 80.09 | -0.19 % | $ 4.66 B | USA |
 |
OraSure Technologies
OSUR
|
-380 K | $ 2.78 | -0.54 % | $ 207 M | USA |
 |
Isoray
ISR
|
2 K | - | 0.03 % | $ 108 M | USA |
 |
iRhythm Technologies
IRTC
|
1.25 M | $ 150.09 | 0.74 % | $ 4.68 B | USA |
 |
LeMaitre Vascular
LMAT
|
205 K | $ 84.08 | 0.26 % | $ 1.89 B | USA |
 |
STERIS plc
STE
|
8.4 M | $ 261.25 | -0.23 % | $ 25.8 B | USA |
 |
Microbot Medical
MBOT
|
2 K | $ 1.84 | -1.34 % | $ 18.8 M |  Israel |
 |
Nephros
NEPH
|
2 K | $ 4.4 | 0.23 % | $ 45.7 M | USA |
 |
Utah Medical Products
UTMD
|
256 K | $ 60.16 | -2.42 % | $ 218 M | USA |
 |
Milestone Scientific
MLSS
|
60.3 K | $ 0.29 | -0.7 % | $ 23.1 M | USA |
 |
Envista Holdings Corporation
NVST
|
-100 K | $ 23.07 | -1.28 % | $ 3.97 B | USA |
 |
Pro-Dex
PDEX
|
533 K | $ 38.84 | -1.43 % | $ 128 M | USA |
 |
Predictive Oncology
POAI
|
3 | - | - | $ 31.1 M | USA |
 |
Pulse Biosciences
PLSE
|
983 K | $ 13.69 | 0.48 % | $ 658 M | USA |
 |
Becton, Dickinson and Company
BDX
|
613 M | $ 201.67 | 0.29 % | $ 58 B | USA |
 |
Repligen Corporation
RGEN
|
8.12 M | $ 151.86 | -2.88 % | $ 8.46 M | USA |
 |
ResMed
RMD
|
3.2 M | $ 251.52 | -2.37 % | $ 36.7 B | USA |
 |
BioLife Solutions
BLFS
|
497 K | $ 22.08 | -2.21 % | $ 1.02 B | USA |
 |
Stereotaxis
STXS
|
1.1 M | $ 2.26 | -3.21 % | $ 182 M | USA |
 |
Retractable Technologies
RVP
|
227 K | $ 0.69 | 0.16 % | $ 20.7 M | USA |
 |
STAAR Surgical Company
STAA
|
815 K | $ 18.79 | -0.8 % | $ 923 M | USA |
 |
Teleflex Incorporated
TFX
|
57 M | $ 105.0 | -0.43 % | $ 4.92 B | USA |
 |
West Pharmaceutical Services
WST
|
-1 M | $ 226.43 | -2.61 % | $ 16.5 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
12 M | $ 12.28 | 0.04 % | $ 2.5 B | USA |